Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective
Authors
Keywords
-
Journal
Clinical and Molecular Hepatology
Volume 29, Issue 2, Pages 242-251
Publisher
The Korean Association for the Study of the Liver
Online
2023-03-21
DOI
10.3350/cmh.2023.0102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
- (2023) Naoya Kato et al. HEPATOLOGY RESEARCH
- Achievement of cancer- and treatment-free status by atezolizumab plus bevacizumab combined with or without curative conversion in patients with transarterial chemoembolization-unsuitable, intermediate-stage hepatocellular carcinoma: A multicenter cohort study.
- (2023) Masatoshi Kudo et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
- (2023) Hideki Iwamoto et al. Clinical and Molecular Hepatology
- Transcatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis.
- (2022) Kazuomi Ueshima et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019
- (2022) Masahito Nakano et al. Scientific Reports
- Clinical Outcomes of Ramucirumab as Post-treatment Following Atezolizumab/Bevacizumab Combination Therapy in Advanced Hepatocellular Carcinoma
- (2022) TEIJI KUZUYA et al. ANTICANCER RESEARCH
- Current Role of Atezolizumab Plus Bevacizumab Therapy in the Sequential Treatment of Unresectable Hepatocellular Carcinoma
- (2022) SHOHEI KOMATSU et al. ANTICANCER RESEARCH
- Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma
- (2022) Hiroki Murai et al. HEPATOLOGY
- Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma
- (2022) Kazuki Maesaka et al. HEPATOLOGY RESEARCH
- Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child‐Pugh class A or B liver function in real‐world clinical practice
- (2022) Takaaki Tanaka et al. HEPATOLOGY RESEARCH
- Artificial intelligence (AI) models for the ultrasonographic diagnosis of liver tumors and comparison of diagnostic accuracies between AI and human experts
- (2022) Naoshi Nishida et al. JOURNAL OF GASTROENTEROLOGY
- Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma
- (2022) Julien Calderaro et al. JOURNAL OF HEPATOLOGY
- Clinical Practice Guidelines for Hepatic Arterial Infusion Chemotherapy with a Port System Proposed by the Japanese Society of Interventional Radiology and Japanese Society of Implantable Port Assisted Treatment
- (2022) Kazuomi Ueshima et al. Liver Cancer
- Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
- (2022) Hideki Iwamoto et al. Clinical and Molecular Hepatology
- Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)
- (2022) Zhenwei Peng et al. JOURNAL OF CLINICAL ONCOLOGY
- Atezolizumab plus Bevacizumab Followed by Curative Conversion (ABC Conversion) in Patients with Unresectable, TACE-unsuitable Intermediate-stage Hepatocellular Carcinoma
- (2022) Masatoshi Kudo Liver Cancer
- Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real‐world data
- (2022) Shigeo Shimose et al. HEPATOLOGY RESEARCH
- Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
- (2022) Takashi Niizeki et al. Targeted Oncology
- The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
- (2022) Tomoki Kimura et al. Cancers
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- (2022) Clinical and Molecular Hepatology
- Sorafenib versus nivolumab after lenvatinib treatment failure in patients with advanced hepatocellular carcinoma
- (2022) Yuna Kim et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Alternating Lenvatinib and Trans-Arterial Therapy Prolongs Overall Survival in Patients with Inter-Mediate Stage HepatoCellular Carcinoma: A Propensity Score Matching Study
- (2021) Shigeo Shimose et al. Cancers
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
- (2021) A. Vogel et al. ANNALS OF ONCOLOGY
- Artificial intelligence in the diagnosis and management of hepatocellular carcinoma
- (2021) Masaya Sato et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Report of the 22nd Nationwide Follow‐Up Survey of Primary Liver Cancer in Japan (2012–2013)
- (2021) Masatoshi Kudo et al. HEPATOLOGY RESEARCH
- Efficacy and Safety of 4 Fractions of Carbon-Ion Radiation Therapy for Hepatocellular Carcinoma: A Prospective Study
- (2021) Kei Shibuya et al. Liver Cancer
- Surgery Versus Radiofrequency Ablation for Small Hepatocellular Carcinoma: a Randomized Controlled Trial (SURF-Trial)
- (2021) Tadatoshi Takayama et al. Liver Cancer
- Off-the-shelf Vδ1 gamma delta T cells engineered with glypican-3 (GPC-3)-specific chimeric antigen receptor (CAR) and soluble IL-15 display robust antitumor efficacy against hepatocellular carcinoma
- (2021) Amani Makkouk et al. Journal for ImmunoTherapy of Cancer
- MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region
- (2021) Takumi Kawaguchi et al. Clinical and Molecular Hepatology
- Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma
- (2020) Shigeo Shimose et al. Oncology Letters
- Trial Design and Endpoints in hepatocellular carcinoma: AASLD Consensus Conference
- (2020) Josep M. Llovet et al. HEPATOLOGY
- A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements
- (2020) Masatoshi Kudo et al. Liver Cancer
- Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse Events
- (2020) Hideki Iwamoto et al. Cancers
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC Guidelines) a 2019 update
- (2019) Norihiro Kokudo et al. HEPATOLOGY RESEARCH
- Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
- (2019) Masatoshi Kudo et al. Cancers
- Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
- (2019) Masaaki Kondo et al. BMC CANCER
- Longitudinal Assessment of Three Serum Biomarkers to Detect Very Early Stage Hepatocellular Carcinoma
- (2018) Jonggi Choi et al. HEPATOLOGY
- Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
- (2016) M. Ikeda et al. ANNALS OF ONCOLOGY
- General Rules for the Clinical and Pathological Study of Primary Liver Cancer, Nationwide Follow-Up Survey and Clinical Practice Guidelines: The Outstanding Achievements of the Liver Cancer Study Group of Japan
- (2015) Masatoshi Kudo et al. DIGESTIVE DISEASES
- Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study
- (2014) Ryosuke Tateishi et al. JOURNAL OF GASTROENTEROLOGY
- Dense Accumulation of Lipiodol Emulsion in Hepatocellular Carcinoma Nodule during Selective Balloon-occluded Transarterial Chemoembolization: Measurement of Balloon-occluded Arterial Stump Pressure
- (2012) Toshiyuki Irie et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Percutaneous Radiofrequency Ablation for Pulmonary Metastases from Hepatocellular Carcinoma: Results of a Multicenter Study in Japan
- (2011) Takao Hiraki et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More